- Home
- ISPC vs IBIO Comparison
ISPC vs IBIO Comparison
Compare ISPC & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- IBIO
- Stock Information
- Founded
- ISPC 2009
- IBIO 2008
- Country
- ISPC United States
- IBIO United States
- Employees
- ISPC N/A
- IBIO N/A
- Industry
- ISPC Precision Instruments
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ISPC Health Care
- IBIO Health Care
- Exchange
- ISPC Nasdaq
- IBIO Nasdaq
- Market Cap
- ISPC 13.9M
- IBIO 11.9M
- IPO Year
- ISPC 2021
- IBIO N/A
- Fundamental
- Price
- ISPC $1.55
- IBIO $0.87
- Analyst Decision
- ISPC
- IBIO Strong Buy
- Analyst Count
- ISPC 0
- IBIO 2
- Target Price
- ISPC N/A
- IBIO $5.50
- AVG Volume (30 Days)
- ISPC 20.5M
- IBIO 1.9M
- Earning Date
- ISPC 11-06-2025
- IBIO 11-11-2025
- Dividend Yield
- ISPC N/A
- IBIO N/A
- EPS Growth
- ISPC N/A
- IBIO N/A
- EPS
- ISPC N/A
- IBIO N/A
- Revenue
- ISPC $5,908,088.00
- IBIO $400,000.00
- Revenue This Year
- ISPC $35.93
- IBIO N/A
- Revenue Next Year
- ISPC N/A
- IBIO N/A
- P/E Ratio
- ISPC N/A
- IBIO N/A
- Revenue Growth
- ISPC N/A
- IBIO 77.78
- 52 Week Low
- ISPC $0.64
- IBIO $0.56
- 52 Week High
- ISPC $8.30
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- ISPC 56.57
- IBIO 55.70
- Support Level
- ISPC $1.47
- IBIO $0.83
- Resistance Level
- ISPC $2.58
- IBIO $0.97
- Average True Range (ATR)
- ISPC 0.47
- IBIO 0.06
- MACD
- ISPC 0.08
- IBIO -0.00
- Stochastic Oscillator
- ISPC 35.83
- IBIO 50.00
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.